Primary plasma cell leukemia in the era of novel agents for myeloma – a multicenter retrospective analysis of outcome

Primary plasma cell leukemia (PPCL) is a rare aggressive form of multiple myeloma (MM), currently arbitrarily defined as the presence of ≥2 × 109/L or 20% clonal plasma cells in the peripheral blood.

Source: Leukemia Research - February 22, 2018 Category: Hematology Authors: Chezi Ganzel, Ory Rouvio, Irit Avivi, Hila Magen, Osnat Jarchowsky, Katrin Herzog, Yossi Cohen, Tamar Tadmor, Netanel A. Horwitz, Merav Leiba, Arnon Nagler, Yael Cohen, Shlomo Bulvik, Aaron Polliack, Jacob M. Rowe, Moshe E. Gatt, on behalf of the Israeli Tags: Research paper Source Type: research